Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Exploration of the Acceptability and Feasibility of a Novel Screening Tool for Anosognosia After Stroke, Designed for Routine Use in Hospital Settings.

NCT06940882 is registered in ClinicalTrials.gov with University of Exeter as lead sponsor.

NCT NCT06940882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06940882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Exploration of the Acceptability and Feasibility of a Novel Screening Tool for Anosognosia After Stroke, Designed for Routine Use in Hospital Settings.
Lead sponsor
University of Exeter
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2025
Completion date
June 30, 2026
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anosognosia, stroke